Light Mode
$90.56 ↑ +0.00 (+0.00%) Trading Up from the previous close of $90.56, $0.15 below the day’s high of $90.71
+7.10 (+8.51%) / 6M
Momentum, market sentiment, and recent alerts
EW reads very good: price sits above both the 20- and 200-day averages, short interest is rising month over month, the 12-month move is +12.1%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.